EUVIMEDEUVIMED entdecken
Open Access

Outcomes after coronary angiography in individuals with elevated lipoprotein(a)

Kelvin Supriami iD, Christian C Faaborg-Andersen, So Mi Jemma Cho, José Roberto Tello-Ayala, Roukoz Abou-Karam, Eugene Pomerantsev, Victoria Viscosi, Sara Haidermota iD, Whitney Hornsby, Pradeep Natarajan iD, Patrick T Ellinor, Michael C Honigberg und 1 weitere

European Journal of Preventive Cardiology · 13.11.2025

DOI: 10.1093/eurjpc/zwaf690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Preventive Cardiology, online erschienen am 13.11.2025. Verfasst von Kelvin Supriami und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 185 Cambridge Street, CPZN 3.187, Boston, MA …. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Indonesian Endowment Fund, NHLBI NIH HHS, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Elevated lipoprotein(a) [Lp(a)] is an independent risk factor for coronary artery disease (CAD). Data on long-term outcomes following invasive coronary angiography (ICA) in those with elevated Lp(a) are limited. This study examined the association of Lp(a) levels with clinical outcomes after index ICA, accounting for baseline atherosclerotic plaque burden. Methods and results Data were from participants with Lp(a) measurement who underwent index ICA between 2000 and 2023. Lp(a) levels were categorized as normal (<75 nmol/L), intermediate (75– < 125 nmol/L), high (125– < 175 nmol/L), and very high (≥175 nmol/L). Angiographic characteristics (severity, burden), CAD presentation (stable, acute), and subsequent clinical outcomes [acute myocardial infarction (AMI), revascularization, in-stent restenosis (ISR), and all-cause mortality] were assessed. Among 5118 participants, 973 (19.0%) had very high Lp(a). Compared with normal Lp(a), very high Lp(a) was associated with severe obstructive CAD {adjusted odds ratio (aOR), 1.51 [95% confidence interval (CI), 1.17–1.96]}, left main disease [aOR, 1.67 (95% CI, 1.22–2.29)], and a 14.04-point higher Gensini score (95% CI, 9.57–18.52). During a median (interquartile range) follow-up of 16.87 (6.38–18.99) years, participants with very high vs. normal Lp(a) had higher risk of AMI [adjusted hazard ratio (aHR), 1.20 (95% CI, 1.05–1.37)], revascularization [aHR, 1.32 (95% CI, 1.13–1.56)], ISR [aHR, 1.28 (95% CI, 1.04–1.56)], and mortality [aHR, 1.19 (95% CI, 1.05–1.34)]. Among 798 individuals undergoing coronary artery bypass grafting surgery after index ICA, those with very high vs. other Lp(a) were more likely to require subsequent percutaneous coronary intervention [aHR, 2.20 (95% CI, 1.06–4.58)].

Conclusion

Elevated Lp(a) levels are associated with increased burden of coronary atherosclerosis and significant residual risk for adverse outcomes following ICA, highlighting a need for targeted risk-reduction strategies.

Schlagwörter

Stichwörter der Autor:innen

Coronary angiographyGensini scoreGraft failureLipoprotein(a)OutcomesRevascularization

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 185 Cambridge Street, CPZN 3.187, Boston, MA 02114, USA.
  • Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, 75 Ames Street, Cambridge, MA 02142, USA.
  • Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 185 Cambridge Street, CPZN 3.128, Boston, MA 02114, USA.
  • Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Integrative Research Center for Cerebrovascular and Cardiovascular Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.

ORCID-Profile: Kelvin Supriami, Sara Haidermota, Pradeep Natarajan, Akl C Fahed

Förderung

  • Indonesian Endowment Fund
  • NHLBI NIH HHS
  • European Union
  • NIH HHS
  • American Heart Association-American Stroke Association
  • Korea Health Industry Development Institute
  • Ministry of Health & Welfare
  • American Heart Association

Zitieren

APA

Supriami, K., Faaborg-Andersen, C. C., Cho, S. M. J., Tello-Ayala, J. R., Abou-Karam, R., Pomerantsev, E., Viscosi, V., Haidermota, S., Hornsby, W., Natarajan, P., Ellinor, P. T., Honigberg, M. C., & Fahed, A. C. (2025). Outcomes after coronary angiography in individuals with elevated lipoprotein(a). European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwaf690

Vancouver

Supriami K, Faaborg-Andersen CC, Cho SMJ, Tello-Ayala JR, Abou-Karam R, Pomerantsev E, et al. Outcomes after coronary angiography in individuals with elevated lipoprotein(a). European Journal of Preventive Cardiology. 2025. doi:10.1093/eurjpc/zwaf690

BibTeX
@article{Supriami2025,
  author = {Supriami, Kelvin and Faaborg-Andersen, Christian C and Cho, So Mi Jemma and Tello-Ayala, José Roberto and Abou-Karam, Roukoz and Pomerantsev, Eugene and Viscosi, Victoria and Haidermota, Sara and Hornsby, Whitney and Natarajan, Pradeep and Ellinor, Patrick T and Honigberg, Michael C and Fahed, Akl C},
  title = {Outcomes after coronary angiography in individuals with elevated lipoprotein(a)},
  journal = {European Journal of Preventive Cardiology},
  year = {2025},
  doi = {10.1093/eurjpc/zwaf690}
}
Kostenlos starten →